Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 22, 2024European Heart Journal - Cardiovascular Pharmacotherapy

Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort study

View Full Paper
Ask AI
Bookmark
Share

Authors

TETalip E ErogluRCRuben CoronelPSPatrick C. Souverein

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Eroglu et al. (2024) studied this question.

synapsesocial.com/papers/68e72babb6db6435876a5b56https://doi.org/10.1093/ehjcvp/pvae022
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Atrial Fibrillation Begets Heart Failure and Vice Versa2016 · 890 citations
  2. 2Sodium-Glucose Cotransporter 2 Inhibitors Potentially Prevent Atrial Fibrillation by Ameliorating Ion Handling and Mitochondrial Dysfunction2020 · 46 citations
  3. 3Benefits of SGLT2 inhibitors in arrhythmias2022 · 36 citations
  4. 4Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in Taiwan2017 · 75 citations
  5. 5Data Resource Profile: Clinical Practice Research Datalink (CPRD)2015 · 2,781 citations